7-117559642-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong
The ENST00000003084.11(CFTR):c.1571G>A(p.Cys524Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,204 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C524R) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000003084.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.1571G>A | p.Cys524Tyr | missense_variant | 11/27 | ENST00000003084.11 | NP_000483.3 | |
CFTR-AS1 | NR_149084.1 | n.221+1091C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFTR | ENST00000003084.11 | c.1571G>A | p.Cys524Tyr | missense_variant | 11/27 | 1 | NM_000492.4 | ENSP00000003084 | P2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460204Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726578
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cystic fibrosis Pathogenic:1Uncertain:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 29, 2016 | The p.C524Y variant (also known as c.1571G>A), located in coding exon 11 of the CFTR gene, results from a G to A substitution at nucleotide position 1571. The cysteine at codon 524 is replaced by tyrosine, an amino acid with highly dissimilar properties. This variant was confirmed in trans with p.F508del in preterm twins with persistent meconium ileus (Puzik A et al. BMC Pediatr, 2014 Jan;14:13). Based on internal structural analysis, this variant is anticipated to result in a significant decrease in structural stability (Atwell S et al. Protein Eng. Des. Sel., 2010 May;23:375-84). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Mar 02, 2018 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 12, 2017 | Variant summary: The CFTR c.1571G>A (p.Cys524Tyr) variant involves the alteration of a conserved nucleotide, is located in ABC transporter type 1, transmembrane domain (InterPro) and is predicted to be damaging by 5/5 in silico tools. This variant is absent in 120778 control chromosomes from ExAC. This variant has been reported in two pre-term twins with lethal course of meconium ileus in compound heterozygous state with a known severe mutation p.Phe508del (Puzik_2014). Parents were genotyped and each was heterozygous carrier for one of the variants. Based on the currently available information, this variant is classified as VUS-possibly pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at